Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 benralizumab study in adults with mild to moderate persistent asthma
2014-004427-40Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Benralizumab with Placebo (2 arms). Primary endpoint: Change from baseline in pre-dose forced expiratory volume in 1 second. Started Nov 2014; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-004427-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004427-40.